Athrombin

Details:

   Warfarin sodium tablet is an anticoagulant, belonging to dicoumarin intermediate anticoagulant, which can inhibit platelet aggregation in blood and prevent it from forming thrombus and blocking blood vessels. Can be used for treating and preventing thromboembolic diseases, and can also be used as an auxiliary drug for myocardial infarction. Prevention and treatment of deep venous thrombosis and pulmonary embolism; Prevention of thromboembolism complications after myocardial infarction (moderate or systemic embolism); Prevention of thromboembolic complications (moderate or systemic embolism) caused by atrial fibrillation, heart valve disease or artificial valve replacement.

    Warfarin sodium is mainly used to treat thromboembolic diseases, such as deep venous thrombosis and thrombophlebitis, which can prevent the formation and development of thrombosis and reduce the incidence and mortality of pulmonary embolism. In addition, it is also used to reduce the incidence of venous thrombosis in major surgery, rheumatic heart disease, artificial heart valve replacement and so on. For patients with myocardial infarction, it can be used as an auxiliary drug, such as the treatment of atrial fibrillation with pulmonary embolism and the auxiliary treatment of coronary artery occlusion. At the same time, it can also be used as a preventive drug for patients with thromboembolism and those at risk of postoperative thromboembolic complications. Telmisartan and its combination in the treatment of essential hypertension with paroxysmal atrial fibrillation can effectively improve the level of cardiac function and blood biochemical indexes, and inhibit the enlargement of left atrial diameter. It has obvious therapeutic effect on elderly patients with slow heart rate atrial fibrillation complicated with acute cerebral infarction, which can improve their coagulation function and blood flow status and reduce their blood viscosity.

    Warfarin sodium tablet is an anticoagulant, which belongs to dicoumarin intermediate anticoagulant. It was first marketed in the United States in 1954. It can inhibit platelet aggregation in blood and prevent it from forming thrombus and blocking blood vessels. Can be used for treating and preventing thromboembolic diseases, and can also be used as an auxiliary drug for myocardial infarction. Warfarin sodium tablets are absorbed rapidly and completely by oral administration, with long action time and high bioavailability of 100%. After absorption, the binding rate with plasma protein is 98% ~ 99%, which can penetrate the placenta and is very rare in breast milk. The disadvantage is that the effect is slow, the effect is too lasting and difficult to control. For those who need rapid anticoagulation, heparin should be used to play a therapeutic role first, and then warfarin should be used to maintain the curative effect. It is mainly accumulated in lung, liver, spleen and kidney. It is metabolized by the liver and its metabolites are excreted by the kidney.